127 related articles for article (PubMed ID: 19241772)
1. Acular LS before and during LASIK for the control of pain: a randomized, masked contralateral eye trial.
Dougherty PJ
J Refract Surg; 2009 Feb; 25(2):210-3. PubMed ID: 19241772
[TBL] [Abstract][Full Text] [Related]
2. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Trattler W; McDonald M
Cornea; 2007 Jul; 26(6):665-9. PubMed ID: 17592313
[TBL] [Abstract][Full Text] [Related]
3. Pain reduction after laser in situ keratomileusis with ketorolac tromethamine ophthalmic solution 0.5%: a randomized, double-masked, placebo-controlled trial.
Price FW; Price MO; Zeh W; Dobbins K
J Refract Surg; 2002; 18(2):140-4. PubMed ID: 11934202
[TBL] [Abstract][Full Text] [Related]
4. Topical ketorolac tromethamine in the reduction of adverse effects of laser in situ keratomileusist.
Kosrirukvongs P; Prabhasawat P; Srivannaboon S; Pornpanich K
J Med Assoc Thai; 2001 Jun; 84(6):804-10. PubMed ID: 11556458
[TBL] [Abstract][Full Text] [Related]
5. Topical bromfenac 0.09% vs. ketorolac 0.4% for the control of pain, photophobia, and discomfort following PRK.
Sher NA; Golben MR; Bond W; Trattler WB; Tauber S; Voirin TG
J Refract Surg; 2009 Feb; 25(2):214-20. PubMed ID: 19241773
[TBL] [Abstract][Full Text] [Related]
6. Analgesic effect of preoperative topical nonsteroidal antiinflammatory drugs on postoperative pain after laser-assisted subepithelial keratectomy.
Kim SK; Hong JP; Nam SM; Stulting RD; Seo KY
J Cataract Refract Surg; 2015 Apr; 41(4):749-55. PubMed ID: 25840299
[TBL] [Abstract][Full Text] [Related]
7. Effects of nonsteroidal ophthalmic drops on epithelial healing and pain in patients undergoing bilateral photorefractive keratectomy (PRK).
Durrie DS; Kennard MG; Boghossian AJ
Adv Ther; 2007; 24(6):1278-85. PubMed ID: 18165210
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery.
Price MO; Price FW
Curr Med Res Opin; 2004 Dec; 20(12):2015-9. PubMed ID: 15701218
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
Solomon KD; Donnenfeld ED; Raizman M; Sandoval HP; Stern K; VanDenburgh A; Cheetham JK; Schiffman R;
J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative ketorolac and eye pain after viteoretinal surgery: a prospective, randomized, placebo-controlled study.
Fekrat S; Marsh MJ; Elsing SH; Raja SC; de Juan E; Campochiaro PA; Haller JA
Retina; 2003 Feb; 23(1):8-13. PubMed ID: 12652225
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Epi-LASIK and off-flap Epi-LASIK for the treatment of low and moderate myopia.
Kalyvianaki MI; Kymionis GD; Kounis GA; Panagopoulou SI; Grentzelos MA; Pallikaris IG
Ophthalmology; 2008 Dec; 115(12):2174-80. PubMed ID: 19041475
[TBL] [Abstract][Full Text] [Related]
12. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
Duong HV; Westfield KC; Chalkley TH
J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
[TBL] [Abstract][Full Text] [Related]
13. Analgesic efficacy and safety of ketorolac after photorefractive keratectomy. Ketorolac Study Group.
Rajpal RK; Cooperman BB
J Refract Surg; 1999; 15(6):661-7. PubMed ID: 10590004
[TBL] [Abstract][Full Text] [Related]
14. Comparison of ketorolac tromethamine, diclofenac sodium, and moist drops for ocular pain after radial keratotomy.
McDonald MB; Brint SF; Caplan DI; Bourque LB; Shoaf K
J Cataract Refract Surg; 1999 Aug; 25(8):1097-108. PubMed ID: 10445196
[TBL] [Abstract][Full Text] [Related]
15. Pre-Emptive Topical Ketorolac Tromethamine 0.5% for Panretinal Photocoagulation.
Chewa Raja JS; Singh S; Ismail F
J Ocul Pharmacol Ther; 2021 Jun; 37(5):313-317. PubMed ID: 33794664
[No Abstract] [Full Text] [Related]
16. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
Heier J; Cheetham JK; Degryse R; Dirks MS; Caldwell DR; Silverstone DE; Rosenthal A
Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
[TBL] [Abstract][Full Text] [Related]
17. Ketorolac for the regression of myopic LASIK overcorrection.
Shaikh NM; Hayes BC; Kaufman SC
Cornea; 2004 May; 23(4):339-44. PubMed ID: 15097126
[TBL] [Abstract][Full Text] [Related]
18. Double-masked comparison of ketorolac tromethamine 0.4% versus nepafenac sodium 0.1% for postoperative healing rates and pain control in eyes undergoing surface ablation.
Lindstrom R; Holland E; Lane S; Raizman M; Reilly C
Cornea; 2008 Apr; 27(3):385-6; author reply 386-7. PubMed ID: 18362679
[No Abstract] [Full Text] [Related]
19. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
Donnenfeld ED; Perry HD; Wittpenn JR; Solomon R; Nattis A; Chou T
J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
[TBL] [Abstract][Full Text] [Related]
20. Intraoperative Patient Experience and Postoperative Visual Quality After SMILE and LASIK in a Randomized, Paired-Eye, Controlled Study.
Damgaard IB; Ang M; Farook M; Htoon HM; Mehta JS
J Refract Surg; 2018 Feb; 34(2):92-99. PubMed ID: 29425387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
